+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Healthtech - Thematic Research

  • ID: 4577077
  • Report
  • May 2018
  • Region: Global
  • 32 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3


  • 23andMe
  • Alphabet
  • BGI Shenzhen
  • Cyberdyne
  • Fitbit
  • iCarbonX
  • MORE
Healthtech - Thematic Research


Global healthcare industry is worth $8 trillion. At over $10,000 per capita, US healthcare spending is 30% higher than the world’s second highest spender-Switzerland-and approximately 6.5 times higher than levels in China. Because of this higher spending, the implication is that the US healthcare sector is wasteful.

There has been a surge of interest in whether or not better technology might extract greater efficiency gains. Thus far, the global healthcare industry-especially the US healthcare industry-has been slow to modernize due to the fact that the industry is complex, risk averse, and highly regulated.

The Internet of Things (IoT) is transforming the healthcare industry. Organizations are utilizing IoT technologies to access real-time data and gain visibility into their operations throughout the manufacturing value chain. For hundreds of years, the key drivers of progress in healthcare were biology and chemistry. Now, they are data science and software.

The global IoT devices market in the healthcare sector is expected to grow at a Compound Annual Growth Rate (CAGR) of 47.3% from 2016 to 2020, to over $500M. One important market driver that is propelling the wider adoption of IoT in healthcare is the convergence of Big Data and IoT, which opens up significant opportunities for the industry overall. Big Healthcare is being gradually undermined by swelling networks of connected biosensors, ubiquitous mobile devices, and cloud-based healthcare apps. Collectively, these phenomena are grouped under the umbrella term, “The Internet of Healthcare Things”.

Six broad technology categories are set to transform the healthcare industry over the next two years: Genomics, Mobile Health, Health Information Technology (IT) Systems, Robotics, Virtual Reality, and 3D Printing. Unless major investment are carried out, in the long term the losers will be Big Pharma and Big Medical Equipment players. However, in the short term, the threat level for these companies is low.

The report "Healthtech - Thematic Research", is part of an ecosystem of thematic investment research reports.The report offers in-depth research intoHealthtech; identifying winners and losers based on technology leadership, market position and other factors.

Companies Mentioned: Qualcomm, Proteus Digital Health, Oxford, Nanopore, Medtronic, Illumina, iCarbonX, IBM Watson, Ginger.io, Fitbit, First Sensor, Enlitic, Cyberdyne, Cerner, Biovotion, BGI Shenzhen, AtomWise, Apple, Alphabet, AliveCor, Agendia, 23andMe


This report is part of our ecosystem of thematic investment research reports, supported by our “thematic engine”.

About the Thematic Research Ecosystem:
  • The author has developed a unique thematic methodology for valuing technology, media and telecom companies based on their relative strength in the big investment themes that are impacting their industry. Whilst most investment research is underpinned by backwards looking company valuation models, the author’s thematic methodology identifies which companies are best placed to succeed in a future filled with multiple disruptive threats. To do this, the author tracks the performance of the top 600 technology, media and telecom stocks against the 50 most important themes driving their earnings, generating 30,000 thematic scores. The algorithms in the author’s “thematic engine” help to clearly identify the winners and losers within the TMT sector. Our 600 TMT stocks are categorised into 18 sectors. Each sector scorecard has a thematic screen, a risk screen and a valuation screen. Our thematic research ecosystem has a three-tiered reporting structure: single theme, multi-theme and sector scorecard. This report is a Multi-Theme report, covering all stocks, all sectors and all themes, giving readers a strong sense of how everything fits together and how conflicting themes might interact with one another.
Reasons to buy
  • Our thematic investment research product, supported by our thematic engine, is aimed at senior (C-Suite) executives in the corporate world as well as institutional investors.
  • Corporations: Helps CEOs in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TMT.
  • Our unique differentiator, compared to all our rival thematic research houses, is that our thematic engine has a proven track record of predicting winners and losers.
Note: Product cover images may vary from those shown
2 of 3


  • 23andMe
  • Alphabet
  • BGI Shenzhen
  • Cyberdyne
  • Fitbit
  • iCarbonX
  • MORE


  • Prevention
  • Diagnosis
  • Treatment
  • Monitoring
  • Recording

  • Genomics
  • Mobile Health
  • Health IT Systems
  • Robotics
  • Virtual and Augmented Reality
  • 3D Printing
  • Digital Health Highlights Across Major Therapy Areas in 2017
  • Oncology
  • Immunology
  • Neurology
  • Ophthalmology
  • Cardiovascular and Metabolic Disorders
  • Infectious Diseases
  • Public Companies
  • Private Healthtech Companies
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Alphabet
  • Apple
  • Cerner
  • Cyberdyne
  • First Sensor
  • Fitbit
  • IBM Watson
  • Illumina
  • Medtronic
  • Qualcomm
  • 23andMe
  • Agendia
  • AliveCor
  • AtomWise
  • BGI Shenzhen
  • Biovotion
  • Enlitic
  • Ginger.io
  • iCarbonX
  • Oxford
  • Nanopore
  • Proteus Digital Health
Note: Product cover images may vary from those shown